New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

by Laura Kelley,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainMost Coloradans look at winter as a time of excitement when the high country turns into our own winter wonderland with
Q & A January 26,2024
Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

Q&A: Why 'Jack Frost' may spoil winter plans for some with autoimmune diseases

by Laura Kelley,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainMost Coloradans look at winter as a time of excitement when the high country turns into our own winter wonderland with
Q & A January 26,2024
New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
Breakthroughs January 26,2024
New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

New 'dictionary' of immune responses reveals far more complexity in the immune system than previously thought

by Allessandra DiCorato,Broad Institute of MIT and HarvardCytokine production map by cell type. Credit:Nature(2023). DOI: 10.1038/s41586-023-06816-9The immune system can carry out ma
Breakthroughs January 26,2024
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp
Oncology January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

Nearly 40% of type 2 diabetes patients stop taking their second-line medication, finds study

byNorthwestern UniversityCredit: Unsplash/CC0 Public DomainMost patients with type 2 diabetes will end up needing to add a second-line medication after metformin—the go-to primary drug for gluco
Breakthroughs January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
New hybrid treatment forces cancer cells to starve

New hybrid treatment forces cancer cells to starve

by Greg Williams,NYU Langone HealthCredit: Unsplash/CC0 Public DomainThe combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.The wor
Oncology January 26,2024
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue
Oncology January 26,2024
Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

Cancer therapy bexmarilimab awakens immune cells to attack tumors that have avoided detection, research finds

byUniversity of TurkuThe image shows cancer cells and macrophage immune cells. The macrophages are depicted in red whereas the cancer cells are the white-grey spots. The nuclei are shown in blue
Oncology January 26,2024
Ozempic mania's billions in bills are coming for US taxpayers

Ozempic mania's billions in bills are coming for US taxpayers

by Simone Foxman, Laura Nahmias, Bloomberg NewsCredit: Markus Winkler from PexelsState and local governments across the US are grappling with a growing problem: Expensive drugs to treat diabetes and o
Breakthroughs January 26,2024
Ozempic mania's billions in bills are coming for US taxpayers

Ozempic mania's billions in bills are coming for US taxpayers

by Simone Foxman, Laura Nahmias, Bloomberg NewsCredit: Markus Winkler from PexelsState and local governments across the US are grappling with a growing problem: Expensive drugs to treat diabetes and o
Breakthroughs January 26,2024
Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

by Alvin Powell, Harvard GazetteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe Food and Drug Administration&nbs
Q & A January 26,2024
Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?

by Alvin Powell, Harvard GazetteScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDThe Food and Drug Administration&nbs
Q & A January 26,2024
Scientists find new, better way to develop vaccines

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display
Public Health & Prevention January 26,2024
Scientists find new, better way to develop vaccines

Scientists find new, better way to develop vaccines

byOxford University PressCredit: CC0 Public DomainAnew paperinBiology Methods & Protocolsindicates that researchers in Germany have developed a new system to display
Public Health & Prevention January 26,2024
Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

byUniversity of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainNew research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy
Breakthroughs January 26,2024
Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

Calcium channel blockers key to reversing myotonic dystrophy muscle weakness, study finds

byUniversity of Rochester Medical CenterCredit: Unsplash/CC0 Public DomainNew research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy
Breakthroughs January 26,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com